New drug targets rare nerve tumors in people with specific gene loss
Disease control
Not yet recruiting
This study tests an experimental drug called BMS-986504 in people with a rare cancer called malignant peripheral nerve sheath tumor (MPNST) that cannot be removed by surgery. Only people whose tumors are missing a gene called MTAP can join. The drug is taken daily by mouth, and t…
Phase: PHASE1, PHASE2 • Sponsor: Ankit Mangla, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC